Key result
Intravenous transplantation of bone marrow mesenchymal stem cells significantly improved myocardial function in mdx mice, including increased left ventricular longitudinal strain (14.17% vs 8.11%, P<0.05).
Why the study?
It was unclear whether transplantation of bone marrow mesenchymal stem cells can improve cardiac function in X-linked muscular dystrophy mice and how best to detect it.
Does intravenous infusion of bone marrow mesenchymal stem cells improve cardiac function as detected by speckle tracking echocardiography in X-Linked muscular dystrophy mice?
Does intravenous infusion of bone marrow mesenchymal stem cells improve cardiac function as detected by speckle tracking echocardiography in X-Linked muscular dystrophy mice?
Intravenous transplantation of bone marrow mesenchymal stem cells significantly improved myocardial function in mdx mice, which was accurately detected early by two-dimensional speckle tracking echocardiography.
BMSC therapy may warrant further preclinical testing in muscular dystrophy models; leaves open any clinical translation pending human trials.
BACKGROUND: Bone marrow mesenchymal stem cells (BMSCs) are commonly used in regenerative medicine. However, it is not clear whether transplantation of BMSCs can improve cardiac function of the X-Linked Muscular Dystrophy Mice (mdx) and how to detect it. We aimed to investigate the role of speckle tracking echocardiography (STE) in detecting cardiac function of the BMSCs-transplanted mdx in comparison with the untreated mdx. METHODS: The experimental mice were divided into the BMSCs-transplanted mdx, untreated mdx, and control mice groups (n = 6 per group). The BMSCs were transplanted via tail vein injections into a subset of mdx at 20 weeks of age. After four weeks, the cardiac functional parameters of all the mice in the 3 groups were analyzed by echocardiography. Then, all the mice were sacrificed, and the cardiac tissues were harvested and analyzed by immunofluorescence. The serum biochemical parameters were also analyzed to determine the beneficial effects of BMSCs transplantation. RESULTS: Traditional echocardiography parameters did not show statistically significant differences after BMSCs transplantation for the three groups of mice. In comparison with the control group, mdx showed significantly lower left ventricular (LV) STE parameters in both the long-axis and short-axis LV images (P < 0.05). However, BMSCs-transplanted mdx showed improvements in several STE parameters including significant increases in a few STE parameters (P < 0.05). Immunofluorescence staining of the myocardium tissues showed statistically significant differences between the mdx and the control mice (P < 0.05), and the mdx transplanted with BMSCs demonstrated significantly improvement compared with the untreated mdx (P < 0.05). CONCLUSION: This study demonstrated that the early reduction in the LV systolic and diastolic function in the mdx were accurately detected by STE. Furthermore, our study demonstrated that the transplantation of BMSCs significantly improved myocardial function in the mdx.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2022) studied Duchenne muscular dystrophy (mdx mouse model) (n=18). Bone marrow mesenchymal stem cells (BMSCs) vs. Vehicle (PBS) was evaluated on Left ventricular longitudinal strain (L-LS) (p=<0.05). Intravenous transplantation of bone marrow mesenchymal stem cells significantly improved myocardial function in mdx mice, including increased left ventricular longitudinal strain (14.17% vs 8.11%, P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: